From: Learning temporal weights of clinical events using variable importance
ADE | Description | Positive | Negative | Events |
---|---|---|---|---|
D611 | Drug-induced aplastic anaemia | 593 | 105 | 2025 |
D642 | Drug-induced secondary sideroblastic anaemia | 217 | 9673 | 6076 |
D695 | Secondary thrombocytopenia | 1246 | 2148 | 4134 |
E273 | Drug-induced adrenocortical insufficiency | 70 | 259 | 1601 |
G620 | Drug-induced polyneuropathy | 96 | 783 | 2448 |
I952 | Drug-induced hypotension | 115 | 1287 | 2933 |
L270 | Drug-induced generalized skin eruption | 182 | 468 | 2480 |
L271 | Drug-induced localized skin eruption | 151 | 498 | 2481 |
M804 | Drug-induced osteoporosis with pathological fracture | 52 | 1170 | 2208 |
M814 | Drug-induced osteoporosis | 57 | 5097 | 4158 |
O355 | Maternal care for damage to fetus by drugs | 146 | 260 | 1277 |
R502 | Drug-induced fever | 80 | 6434 | 5151 |
T782 | Adverse effects: anaphylactic shock | 131 | 856 | 2639 |
T783 | Adverse effects: angioneurotic oedema | 283 | 720 | 2639 |
T784 | Adverse effects: allergy | 574 | 415 | 2635 |
T801 | Vascular complications following infusion, transfusion and therapeutic injection | 66 | 609 | 2063 |
T808 | Other complications following infusion, transfusion and therapeutic injection | 538 | 138 | 2060 |
T886 | Drug-induced anaphylactic shock | 89 | 1506 | 3765 |
T887 | Unspecified adverse effect of drug or medicament | 1047 | 550 | 3770 |